71
TITLE: Proliferative/angiogenic genetic profile is associated with progression-free-interval in androgen blockade treated prostate cancer patients  Full Text
AUTHORS: Teixeira, AL; Ribeiro, R; Morajs, A; Lobo, F; Fraga, A; Calais Da Silva, FM; Calais Da Silva, FE; Pina, F; Rui Medeiros ;
PUBLISHED: 2008, SOURCE: 20th Meeting of the European-Association-for-Cancer-Research in EJC SUPPLEMENTS, VOLUME: 6, ISSUE: 9
INDEXED IN: WOS CrossRef
72
TITLE: Genetic polymorphism of the epidermal growth factor gene-value for the treatment of non-small cell lung cancer (NSCLC)  Full Text
AUTHORS: Araujo, A; Araujo, AP; Teixeira, AL; Coelho, A; Ribeiro, R; Azevedo, I; Catarino, R; Pinto, D; Soares, M; Rui Medeiros ;
PUBLISHED: 2007, SOURCE: 14th European Cancer Conference (ECCO 14) in EJC SUPPLEMENTS, VOLUME: 5, ISSUE: 4
INDEXED IN: WOS CrossRef
73
TITLE: Bone alkaline phosphatase besides intact parathyroid hormone in hemodialysis patients - Any advantage?
AUTHORS: Jorge, C; Gil, C; Possante, M; Silva, E; Andrade, R; Santos, N; Cruz, A; Teixeira, R; Ferreira, AB;
PUBLISHED: 2005, SOURCE: NEPHRON CLINICAL PRACTICE, VOLUME: 101, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef
74
TITLE: Influence of the interval between the administration of doxorubicin and paclitaxel on the pharmacokinetics of these drugs in patients with locally advanced breast cancer  Full Text
AUTHORS: Moreira, A; Lobato, R; Morais, J; Silva, S; Ribeiro, J; Figueira, A; Vale, D; Sousa, C; Araujo, F; Fernandes, A; Oliveira, J; Passos Coelho, JL;
PUBLISHED: 2001, SOURCE: CANCER CHEMOTHERAPY AND PHARMACOLOGY, VOLUME: 48, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef
Page 8 of 8. Total results: 74.